Ajer Jeffrey Robert Insider Trades

Insider Trading History

Track insider trading activity for Ajer Jeffrey Robert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Nektar Therapeutics
Nektar Therapeutics NKTR
Director
Holding Value $534k 8,000 shares
Last Trade
Sep 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$455k 8,000 shares
$56.90
$66.69
Viridian Therapeutics
Viridian Therapeutics VRDN
Director
Holding Value $363k 21,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$304k 21,000 shares
$14.47
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Director
Holding Value $726k 42,000 shares
Last Trade
Apr 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$495k 42,000 shares
$11.78
$17.28
Nektar Therapeutics
Nektar Therapeutics NKTR
Director
Holding Value $8M 120,000 shares
Last Trade
Sep 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 120,000 shares
$1.26
$66.69
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $3.77M 66,767 shares
Last Trade
May 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$415k 5,000 shares
$82.91
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $4.05M 71,767 shares
Last Trade
Apr 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.2k 300 shares
$80.76
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $4.04M 71,467 shares
Last Trade
Mar 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.89M 22,580 shares
$83.87
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $5.31M 94,047 shares
Last Trade
Mar 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$348k 4,000 shares
$87.07
$56.50
Nektar Therapeutics
Nektar Therapeutics NKTR
Director
Holding Value $5.67M 85,000 shares
Last Trade
Sep 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.8k 85,000 shares
$0.68
$66.69
Nektar Therapeutics
Nektar Therapeutics NKTR
Director
Holding Value $2.28M 34,153 shares
Last Trade
Sep 18, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.01k 4,359 shares
$0.69
$66.69
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $3.44M 60,804 shares
Last Trade
Aug 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$450k 5,000 shares
$90.00
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $3.72M 65,804 shares
Last Trade
Apr 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.5k 318 shares
$96.04
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $3.7M 65,486 shares
Last Trade
Mar 16, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.92M 20,510 shares
$93.41
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $4.86M 85,996 shares
Last Trade
Mar 15, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$348k 3,971 shares
$87.74
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $5.08M 89,967 shares
Last Trade
Mar 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.91M 33,180 shares
$87.74
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $4.51M 79,857 shares
Last Trade
Feb 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.86M 38,769 shares
$99.59
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $2.56M 45,263 shares
Last Trade
Jan 25, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.67M 49,000 shares
$115.69
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $5.09M 90,088 shares
Last Trade
Jan 25, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.69M 49,000 shares
$116.03
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Jan 25, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.43M 46,800 shares
$116.03
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Commercial Officer
Holding Value $2.32M 41,088 shares
Last Trade
Nov 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$258k 3,000 shares
$86.12
$56.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up